C181 (Rizatriptan benzoate 5 mg (base))

Pill imprint C181 has been identified as Rizatriptan benzoate 5 mg (base).

Rizatriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Rizatriptan 5 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Rizatriptan benzoate

Imprint:

C181

Strength:

5 mg (base)

Color:

Pink

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Antimigraine agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Cipla USA Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.